Toviaz Side Effects

Generic name: fesoterodine

Medically reviewed by Drugs.com. Last updated on Apr 27, 2024.

Note: This document provides detailed information about Toviaz Side Effects associated with fesoterodine. Some dosage forms listed on this page may not apply specifically to the brand name Toviaz.

Applies to fesoterodine: oral tablet extended release.

Serious side effects of Toviaz

Along with its needed effects, fesoterodine (the active ingredient contained in Toviaz) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking fesoterodine:

More common side effects

• difficulty having a bowel movement
• dry mouth

Less common side effects

• bladder pain
• bloating or swelling of the face, arms, hands, lower legs, or feet
• bloody or cloudy urine
• body aches or pain
• burning feeling while urinating
• chills
• cough
• decrease in frequency of urination
• decrease in urine volume
• difficult or painful urination
• difficulty in breathing
• difficulty in passing urine (dribbling)
• dry eyes
• ear congestion
• fever
• frequent urge to urinate
• headache
• loss of voice
• lower back or side pain
• rapid weight gain
• runny or stuffy nose
• sneezing
• sore throat
• tingling of the hands or feet
• unusual tiredness or weakness
• unusual weight gain or loss

Incidence not known

• blurred vision
• fast, irregular, pounding, or racing heartbeat or pulse

Other side effects of Toviaz

Some side effects of fesoterodine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common side effects

• back pain
• belching
• dry throat
• heartburn
• indigestion
• nausea
• rash
• stomach discomfort, upset, or pain
• trouble sleeping

Incidence not known

• dizziness
• itching skin

For healthcare professionals

Applies to fesoterodine: oral tablet extended release.

General adverse events

Most frequently reported adverse events with a frequency of 4% or greater in adult patients with overactive bladder (OAB) were dry mouth and constipation.

Most frequently reported adverse reactions with a frequency of 2% or great in pediatric patients with neurogenic detrusor overactivity (NDO) were diarrhea, urinary tract infection (UTI), dry mouth, constipation, abdominal pain, nausea, increased weight, and headache.^[Ref]

Cardiovascular

• Uncommon (0.1% to 1%): Tachycardia, palpitations
• Postmarketing reports: Palpitations
• Frequency not reported: Electrocardiogram QT corrected interval prolongation^[Ref]

Dermatologic

• Uncommon (0.1% to 1%): Rash, dry skin, pruritus
• Rare (less than 0.1%): Angioedema, urticaria^[Ref]

Gastrointestinal

• Very common (10% or more): Dry mouth (34.6%)
• Common (1% to 10%): Abdominal pain, diarrhea, dyspepsia, constipation, nausea, upper abdominal pain
• Uncommon (0.1% to 1%): Abdominal discomfort, flatulence, gastroesophageal reflux
• Frequency not reported: Diverticulitis, irritable bowel syndrome^[Ref]

Genitourinary

• Common (1% to 10%): Dysuria
• Uncommon (0.1% to 1%): Urinary tract infection, urinary retention (e.g., feeling of residual urine, micturition disorder), urinary hesitation^[Ref]

Hepatic

• Uncommon (0.1% to 1%): Increased alanine aminotransferase (ALT), increased gamma glutamyltransferase (GGT)^[Ref]

Hypersensitivity

• Postmarketing reports: Hypersensitivity reactions (e.g., angioedema with airway obstruction, face edema)^[Ref]

Immunologic

• Common (1% to 10%): Infections^[Ref]

Musculoskeletal

• Common (1% to 10%): Back pain^[Ref]

Nervous system

• Common (1% to 10%): Dizziness, headache
• Uncommon (0.1% to 1%): Dysgeusia, somnolence^[Ref]

Ocular

• Common (1% to 10%): Dry eye
• Uncommon (0.1% to 1%): Blurred vision^[Ref]

Other

• Common (1% to 10%): Increased weight
• Uncommon (0.1% to 1%): Peripheral edema, vertigo, fatigue^[Ref]

Psychiatric

• Common (1% to 10%): Insomnia
• Rare (0.01% to 0.1%): Confusional state^[Ref]

Respiratory

• Common (1% to 10%): Dry throat, Upper respiratory tract infection
• Uncommon (0.1% to 1%): Pharyngolaryngeal pain, cough, nasal dryness^[Ref]

Further information

Toviaz side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer